RBL Figure 1
Innovation Pharmaceuticals Receives Data Supporting Brilacidin’s Direct Inhibition of SARS-CoV-2, the Novel Coronavirus Responsible for COVID-19
April 01, 2020 08:21 ET | Innovation Pharmaceuticals Inc.
WAKEFIELD, Mass., April 01, 2020 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today it has received data...
1Drop inc., grâce au
1Drop inc., grâce aux efforts de son distributeur canadien exclusif Luminarie Canada, reçoit l'approbation du 1COPY ™ COVID-19 QPCR  KIT en vertu de l'arrêté d’urgence de la Ministre de la Santé
March 31, 2020 19:17 ET | Luminarie Canada Inc.
Le 1copy ™ COVID-19 qPCR kit permet l’obtention de résultats en moins de 2 heures. Test hautement sensible: limite de détection de 200 copies de génome par mL, ce qui est équivalent à 4 copies de...
Luminarie-logo.jpg
1Drop inc., through the efforts of its exclusive Canadian distributor Luminarie Canada, receives approval of its 1copy™ COVID-19 qPCR Multi Kit under the Minister of Health’s Interim Order
March 31, 2020 19:17 ET | Luminarie Canada Inc.
1copy™ COVID-19 qPCR Multi Kit has a short measurement time of less than 2 hours. Highly Sensitive Assay: Limit of detection of 200 genome copies per mL, which is equivalent to 4 genome copies...
15-SORRENTO-Therapeutics-Logo-FINAL.png
SORRENTO AND THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON ENTER INTO PRECLINICAL TESTING AGREEMENT FOR COVID-19 THERAPEUTIC CANDIDATES
March 31, 2020 14:00 ET | Sorrento Therapeutics, Inc.
SAN DIEGO, March 31, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento"), announced it has entered into a research testing agreement with The University of Texas Medical...
Cue_Logo.png
Cue Health Awarded $13 Million for Rapid, Portable, Point-of-Care COVID-19 Test by U.S. Department of Health and Human Services Biomedical Advanced Research and Development Authority (“BARDA”)
March 31, 2020 09:05 ET | Cue Health Inc.
SAN DIEGO, March 31, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (“Cue”), a healthcare technology company, announced that is has been awarded a $13 million contract to accelerate the development,...
TBIO.jpg
Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
March 27, 2020 02:00 ET | Translate Bio, Inc.
The two companies will jointly investigate multiple candidates with the goal of advancing an efficacious and safe SARS-CoV-2 vaccine into clinical development PARIS and LEXINGTON, Mass., March 27,...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
March 25, 2020 10:00 ET | Sorrento Therapeutics, Inc.
STI-6991 is an I-CellTM COVID-19 cellular vaccine made of replication-deficient human erythroleukemia K562 cells expressing membrane-bound S1 protein of the SARS-CoV-2 virusThe I-Cell vaccine is...
TOMI Environmental Solutions, Inc. Logo
STERAMIST UTILIZED BY CVS PHARMACY IN RESPONSE TO CORONAVIRUS
March 23, 2020 09:30 ET | TOMI Environmental Solutions, Inc.
BEVERLY HILLS, Calif., March 23, 2020 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (OTCQB:TOMZ), is a global company specializing in disinfection and decontamination, utilizing...
15-SORRENTO-Therapeutics-Logo-FINAL.png
SORRENTO AND SMARTPHARM TO COLLABORATE TO DEVELOP NOVEL GENE-ENCODED ANTIBODY VACCINE INTENDED TO PROTECT AGAINST COVID-19
March 23, 2020 09:00 ET | Sorrento Therapeutics, Inc.
SAN DIEGO and BOSTON, March 23, 2020 (GLOBE NEWSWIRE) -- In response to the government call for rapidly deployable countermeasures, Sorrento Therapeutics, Inc. (Nasdaq: SRNE, Sorrento) and...
15-SORRENTO-Therapeutics-Logo-FINAL.png
SORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR POTENTIAL PREVENTION AND TREATMENT OF SARS-COV-2 CORONAVIRUS DISEASE (COVID-19)
March 20, 2020 07:00 ET | Sorrento Therapeutics, Inc.
COVIDTRAPTM is a proprietary ACE2-Fc protein that binds to the S1 domain of the spike protein of the SARS-CoV-2 virus;COVIDTRAP is designed to block the SARS-CoV-2 virus from binding and infecting...